tetano
Editor, Senior Moderator
Ann Pharm Fr. 2010 Sep;68(5):269-74. Epub 2010 Jun 8.
[Influenza A/H1N1v 2009 during pregnancy and breastfeeding: Which antiviral to choose?]
[Article in French]
Skalli S, Ferreira E, Bussi?res JF, Allenet B.
Unit? de recherche en pratique pharmaceutique, d?partement de pharmacie, centre hospitalier universitaire Sainte-Justine, 3175, chemin de la C?te-Sainte-Catherine, Montr?al, H3T 1C5, Canada; UF pharmacie clinique, p?le pharmacie, centre hospitalier universitaire de Grenoble, BP 217, 38043 Grenoble cedex 09, France.
Abstract
Pregnant women are at increased risk of severe complications associated with H1N1 pandemic influenza. Fever and inflammatory syndrome associated with the infection may also be deleterious for the developing fetus. Therefore, early antiviral treatment is recommended. Oseltamivir and zanamivir are the two therapeutic options available indicated in the treatment of H1N1 influenza; however, limited data is published on their use during pregnancy and lactation. In this review, we will focus on the effects of H1N1 during pregnancy and on data safety of antivirals during pregnancy and lactation. Main health authorities recommendations for H1N1 influenza treatment of pregnant women will also be presented.
PMID: 20849997 [PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/20849997
[Influenza A/H1N1v 2009 during pregnancy and breastfeeding: Which antiviral to choose?]
[Article in French]
Skalli S, Ferreira E, Bussi?res JF, Allenet B.
Unit? de recherche en pratique pharmaceutique, d?partement de pharmacie, centre hospitalier universitaire Sainte-Justine, 3175, chemin de la C?te-Sainte-Catherine, Montr?al, H3T 1C5, Canada; UF pharmacie clinique, p?le pharmacie, centre hospitalier universitaire de Grenoble, BP 217, 38043 Grenoble cedex 09, France.
Abstract
Pregnant women are at increased risk of severe complications associated with H1N1 pandemic influenza. Fever and inflammatory syndrome associated with the infection may also be deleterious for the developing fetus. Therefore, early antiviral treatment is recommended. Oseltamivir and zanamivir are the two therapeutic options available indicated in the treatment of H1N1 influenza; however, limited data is published on their use during pregnancy and lactation. In this review, we will focus on the effects of H1N1 during pregnancy and on data safety of antivirals during pregnancy and lactation. Main health authorities recommendations for H1N1 influenza treatment of pregnant women will also be presented.
PMID: 20849997 [PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/20849997